Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Hospira, Inc.    HSP   US4410601003

HOSPIRA, INC. (HSP)

11
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on HOSPIRA, INC.
05/20 HOSPIRA : Alliance for Health Reform Bring Food and Drug Administration, Industr..
05/19 HOSPIRA : The Alliance for Health Reform (AHR) - Briefing
05/18DJEndo to Buy Generics Maker Par Pharma for $8 Billion -- 4th Update
05/18DJEndo to Buy Generics Maker Par Pharma for $8 Billion -- 3rd Update
05/18DJEndo to Buy Generics Maker Par Pharma for $8 Billion -- 2nd Update
05/18DJEndo to Buy Generics Maker Par Pharma for About $8 Billion -- Update
05/14 HOSPIRA : Patent Issued for User Interface Improvements for Medical Devices
05/14 HOSPIRA : Patent Issued for Spray Drying Vancomycin
05/14 PFIZER : BRIEF: Federal Trade Commission seeks more info on Pfizer-Hospira deal
05/14 PFIZER : "We realize Israel has vast experience"
05/14DJPFIZER : Receives Second Request From FTC
05/14DJPFIZER : Receives Second Request From FTC Over Hospira Deal
05/14 PFENEX : Reports First Quarter 2015 Results and Provides Business Update
05/13 HOSPIRA : shareholders approve Pfizer deal (BRIEF)
05/13 HOSPIRA : Shareholders Approve Merger of Hospira and Pfizer at Special Meeting
05/13 HOSPIRA : LifeCare PCA3 and PCA5 Infusion Pump Systems by Hospira: FDA Safety Co..
05/12 HOSPIRA : Submission of Matters to a Vote of Security Holders (form 8-K)
05/06 Alexion to bolster rare disease offering with $8.4 billion deal
05/06 HOSPIRA : to begin laying off workers at Clayton plant (BRIEF)
05/01 HOSPIRA : Statement On FDA's Final Biosimilar Guidance Documents
05/01 HOSPIRA : Statement On FDA's Final Biosimilar Guidance Documents
04/28 HOSPIRA : earnings rise 11 percent with Pfizer deal pending
04/28DJPFIZER : Trims Outlook on Stronger Dollar -- Update
04/28DJHospira Profit Easily Tops Expectations as Injectables Remain Strong
04/28DJPfizer, Merck and Bristol-Myers Squibb Report Solid Results
04/28 HOSPIRA : Management's Discussion and Analysis of Financial Condition and Result..
04/28 HOSPIRA : tops Street 1Q forecasts
04/28 HOSPIRA : Results of Operations and Financial Condition, Financial Statements an..
04/28DJPFIZER : Trims Outlook on Stronger Dollar
04/24 HOSPIRA : Leadership Presents at Preeminent European Biosimilars Forum, Announce..
04/22DJMeet Pharma's Newest Movers and Shakers, Driving M&A
04/22DJMeet Pharma's Newest Movers and Shakers, Driving M&A
04/18 HOSPIRA : Sets Date for 1st-Quarter 2015 Results Release
04/14 Banks see talent flee amid healthcare M&A boom
04/14 HOSPIRA : Schedules 1st-Quarter 2015 Results Release
04/13 HOSPIRA : Hope for Greater Access for Patients to Biosimilar Medicines
04/10 HOSPIRA : Schedules Date to Report First-Quarter 2015 Results
04/08 Generic drugmaker Mylan offers $29 billion for Perrigo
04/07 HOSPIRA : to Announce First-Quarter 2015 Results on April 28, 2015
04/07 HOSPIRA : BRIEF: FDA: Hospira's corrective actions at Italy plant weren't enough
04/07DJHospira Gets Warning Letter on Quality Issues at Italy Plant
04/07 HOSPIRA : Other Events (form 8-K)
04/01 HOSPIRA : Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates..
03/30 HOSPIRA : INFLECTRA™ (Infliximab) Now Available in Canada
03/30 HOSPIRA : INFLECTRA(TM) (Infliximab) Now Available in Canada
03/27 HOSPIRA : first biosimilar could be its first to gain FDA approval
03/27 HOSPIRA : McPherson, Kansas Company Applies to DEA to Import Controlled Substanc..
03/27 HOSPIRA : Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates..
03/27 Importer of Controlled Substances Application: HOSPIRA (Importer of Controlle..
03/18 HOSPIRA : Statement on FDA Approval of the First Biosimilar in the United States
03/15 PFENEX : Reports Fourth Quarter and Full Year 2014 Results and Provides Business..
03/13 HOSPIRA : Chicago Tribune Phil Rosenthal column
03/06 HOSPIRA : Inflectra™ (infliximab) patient registry reports interim results..
03/06 HOSPIRA : Statement on FDA Approval of the First Biosimilar in the United States
03/06 HOSPIRA : Statement on FDA Approval of the First Biosimilar in the United States
03/05 AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal
03/05 Biotech buys get pharma M&A off to flying start in 2015
03/05 AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal
03/04 BIOGEN IDEC : ISPE Carolina-South Atlantic Chapter Life Sciences Technology Conf..
02/27 HOSPIRA : Other Events (form 8-K)
02/25DJGeneric Copies of Remicade Go on Sale in Europe
02/25 Biosimilar copies of blockbuster drug launch in major EU markets
02/23 HOSPIRA : NYSE:HSP) Investor Alert: Lawsuit Against Takeover Filed
02/19 HOSPIRA : Inflectra(TM) (infliximab) patient registry reports interim results in..
02/18 HOSPIRA : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of B..
02/17 HOSPIRA : SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of..
02/17 HOSPIRA : introduces first biosimilar mAb Inflectra in some European markets
02/16 HOSPIRA : Launches Biosimilar Inflectra In Major European Markets
02/16 HOSPIRA : launches first biosimilar monoclonal antibody (mAb) Inflectra™ (..
02/16 HOSPIRA : launches first biosimilar monoclonal antibody (mAb) Inflectra(TM) (inf..
02/12DJPainkiller in Short Supply Following Hospira Recall -- Update
02/12 HOSPIRA : earnings hit some targets, miss on others
02/12DJHospira Profit Tops Expectations on Injectables Strength
02/12 HOSPIRA : Management's Discussion and Analysis of Financial Condition and Result..
02/12 HOSPIRA : tops 4Q profit forecasts
1  2  3  4  5  6  7Next
Advertisement
Chart
Duration : Period :
Hospira, Inc. Technical Analysis Chart | HSP | US4410601003 | 4-Traders
Income Statement Evolution
More Financials